spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  The Column Group 

 HSMN NewsFeed - 19 Jul 2023
Velia Therapeutics Announces Appointment of Veteran Drug Developer, John McHutchison, AO, MD as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 May 2022
Remix Therapeutics Closes $70 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 23 Feb 2022
Plexium Announces $102M Financing To Advance Pipeline Of Targeted Protein Degradation Therapies And Technology Platform
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 9 Sep 2021
Obsidian Therapeutics Announces Closing of $115 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Aug 2021
Remix Therapeutics Names Peter Smith, PhD, as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 May 2021
Appia Bio Launches With $52 Million Series A Financing and Establishes Scientific Advisory Board
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 8 Dec 2020
Remix Therapeutics Launches with $81 Million Financing to Develop Small Molecule Therapies Designed to Reprogram RNA Processing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 25 Mar 2020
Kallyope Inc. Announces $112M Series C Financing to Support First Clinical Trials and Advance Portfolio of Programs Targeting the Gut-Brain Axis
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 Nov 2019
A2 Biotherapeutics Emerges From Stealth Mode With $57M Series A To Develop A Pipeline Of Selective Tumor Cell Therapeutics
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 3 Oct 2019
Tenaya Therapeutics Closes $92 Million Series B Financing
Biopharmaceuticals Cardiology Venture Capital Personnel
 HSMN NewsFeed - 26 Nov 2018
ORIC Pharmaceuticals Appoints Matt Panuwat as Chief Business Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 17 Sep 2018
ORIC Pharmaceuticals Appoints Pratik Multani, MD, as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 30 Jul 2018
Tenaya Therapeutics Appoints Faraz Ali as Chief Executive Officer
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 7 May 2018
ORIC Has Appointed Jacob Chacko, MD as Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Feb 2018
Kallyope Inc. Announces $66M Series B Financing to Advance Programs Targeting the Gut-Brain Axis
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 20 Dec 2017
ORIC Has Appointed Rich Heyman, PhD as Acting Chief Executive Officer and Leonard Reyno, MD as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 1 Nov 2017
Tenaya Therapeutics Appoints Tim Hoey, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 24 Jul 2017
eFFECTOR Therapeutics Completes $38.6 Million Series C Financing
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 15 Sep 2016
Peloton Therapeutics Completes $52.4 Million Private Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 22 Dec 2015
eFFECTOR Therapeutics Raises $40 Million Series B Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 15 Dec 2015
eFFECTOR Therapeutics Appoints Alana McNulty Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 May 2014
Third Rock Ventures and The Column Group Launch Nurix with $25.1 Million Financing to Target Key Regulatory Pathway
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 Jan 2014
Igenica Raises $14 Million in Additional Series C Funding to Advance Product Pipeline and Technology Platform
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 30 Oct 2013
Immune Design Raises Up to $49 Million Series C Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 16 Oct 2013
Seragon Pharmaceuticals Raises $30M in Series A Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 7 Mar 2013
PTC Therapeutics Closes $60 Million Private Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 4 Oct 2012
Aragon Pharmaceuticals Raises $50 Million in Series D Financing to Advance Promising Therapeutic Candidates for Hormone-Driven Cancers
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 27 Mar 2012
Constellation Pharmaceuticals Appoints Keith E. Dionne, Ph.D., as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Mar 2012
Aragon Pharmaceuticals Secures $42 Million in Series C Financing to Advance Pipeline of Therapies Targeting Hormone-Driven Cancers
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 7 Jun 2011
Cyterix Pharmaceuticals Raises $9.2 Million in a Series A Venture Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 Jun 2011
Constellation Pharmaceuticals Raises $15 Million in Additional Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 10 Feb 2011
3-V Biosciences Promotes Stephen R. Brady to Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Feb 2011
Constellation Pharmaceuticals Expands Leadership Team with Drug Development Industry Veterans
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Jul 2010
Immune Design Corp. Raises $32 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Jun 2010
3-V Biosciences Appoints Edward M. Connor, Jr., MD, Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jun 2010
Constellation Pharmaceuticals Closes $22 Million in Series B Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 Apr 2010
Aragon Pharmaceuticals Secures $22 Million in Series B Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 20 Jan 2010
Constellation Pharmaceuticals Appoints Industry Veteran Garen Bohlin to Senior Management Group
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jan 2010
Constellation Pharmaceuticals Appoints Kerry K. Reinertsen, Ph.D. as Company's Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Dec 2009
PTC Therapeutics Closes $50 Million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 Sep 2009
Variation Biotechnologies Names Jeff Baxter CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Sep 2009
Constellation Pharmaceuticals Appoints Renowned Cancer Biologist Edward E. Harlow, Jr., Ph.D. as Company's CSO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Aug 2009
Constellation Pharmaceuticals, Inc. Appoints Mark A. Goldsmith, M.D., Ph.D. as CEO and Closes $17 Million in Funding
Biopharmaceuticals Personnel Venture Capital
 HSMN NewsFeed - 13 Aug 2009
Constellation Pharmaceuticals, Inc. Appoints Mark A. Goldsmith, M.D., Ph.D. as CEO and Closes $17 Million in Funding
Biopharmaceuticals Personnel Venture Capital
 HSMN NewsFeed - 20 May 2009
Aragon Pharmaceuticals Announces $8 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 23 Jun 2008
Immune Design Announces $18 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Apr 2008
Constellation Pharmaceuticals Closes $32 Million in Series A Funding
Biopharmaceuticals Venture Capital
Return to NewsFeed  
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!